Nanotechnology Now

Our NanoNews Digest Sponsors

Home > News > Arrowhead Announces Issuance of Patent

August 16th, 2006

Arrowhead Announces Issuance of Patent

Abstract:
Arrowhead Research Corporation (Nasdaq:ARWR) announced today that U.S. Patent No. 7,091,192, titled "Linear Cyclodextrin Copolymers," has been issued to the California Institute of Technology. The patent is exclusively licensed to Arrowhead's majority-owned subsidiary, Insert Therapeutics, a company commercializing delivery-enhanced therapeutics using a patented class of polymeric systems.

Source:
businesswire

Bookmark:

Related News Press

Nanomedicine

Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025

Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025

SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025

How a milk component could eliminate one of the biggest challenges in treating cancer and other disease, including rare diseases: Nebraska startup to use nanoparticles found in milk to target therapeutics to specific cells January 17th, 2025

Announcements

Development of 'transparent stretchable substrate' without image distortion could revolutionize next-generation displays Overcoming: Poisson's ratio enables fully transparent, distortion-free, non-deformable display substrates February 28th, 2025

Unraveling the origin of extremely bright quantum emitters: Researchers from Osaka University have discovered the fundamental properties of single-photon emitters at an oxide/semiconductor interface, which could be crucial for scalable quantum technology February 28th, 2025

Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025

Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

	The latest news from around the world, FREE

Premium Products
	Only the news you want to read!  Learn More
	Full-service, expert consulting  Learn More

Nanotechnology Now Featured Books

© Copyright 1999-2023 7th Wave, Inc. All Rights Reserved

PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE